Skip to main content
. 2021 Jan 14;76(4):1001–1009. doi: 10.1093/jac/dkaa543

Figure 1.

Figure 1.

MICs (mg/L) of meropenem, colistin, amikacin and rifampicin and their combinations (determined using phenotypic and conventional methods). Additional log reduction achieved by combination treatment above the best mono treatment is also shown. FICI data show the synergistic, indifferent or antagonistic effects of combination treatments. CST, colistin; MEM, meropenem; RIF, rifampicin; AMK, amikacin.